Research & Literature

Diagnosis of unstable angina pectoris has declined markedly with the advent of more sensitive troponin assays.

D'Souza M, Sarkisian L, Saaby L, et al.

The American journal of medicine 2015; (128(8)):852-60.

Cardiac rehabilitation and survival in a large representative community cohort of Dutch patients.

de Vries H, Kemps HM, van Engen-Verheul MM, et al.

European heart journal 2015; (36(24)):1519-28 doi:10.1093/eurheartj/ehv111.

P2Y12 antagonists in non-ST-segment elevation acute coronary syndromes: latest evidence and optimal use.

Norgard NB, DiNicolantonio JJ

Therapeutic advances in chronic disease 2015; (6(4)):204-18 doi:10.1177/2040622315584113.

Home-based versus centre-based cardiac rehabilitation.

Taylor RS, Dalal H, Jolly K, et al.

The Cochrane database of systematic reviews 2015; CD007130 doi:10.1002/14651858.CD007130.pub3.

Meta-Analysis of Radial Versus Femoral Access for Percutaneous Coronary Interventions in Non-ST-Segment Elevation Acute Coronary Syndrome.

Bavishi C, Panwar SR, Dangas GD, et al.

The American journal of cardiology 2016; (117(2)):172-8.

Validity of the updated GRACE risk predictor (version 2.0) in patients with non-ST-elevation acute coronary syndrome.

Akyuz S, Yazici S, Bozbeyoglu E, et al.

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 2016; (35(1)):25-31.

Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T.

Mueller C, Giannitsis E, Christ M, et al.

Annals of emergency medicine 2016; (68(1)):76-87.e4.

Prognostic value of dynamic electrocardiographic T wave changes in non-ST elevation acute coronary syndrome.

Sarak B, Goodman SG, Yan RT, et al.

Heart (British Cardiac Society) 2016; (102(17)):1396-402 doi:10.1136/heartjnl-2015-309161.

Clinical Spectrum and Outcome of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome and No Obstructive Coronary Atherosclerosis.

Lanza GA, Careri G, Stazi A, et al.

Circulation journal : official journal of the Japanese Circulation Society 2016; (80(7)):1600-6 doi:10.1253/circj.CJ-16-0145.

Coronary plaque rupture with subsequent thrombosis typifies the culprit lesion of non-ST-segment-elevation myocardial infarction, not unstable angina: non-ST-segment-elevation acute coronary syndrome study.

Sakaguchi M, Ehara S, Hasegawa T, et al.

Heart and vessels 2017; (32(3)):241-251 doi:10.1007/s00380-016-0862-6.

Routine invasive versus selective invasive strategies for Non-ST-elevation acute coronary syndromes: An Updated meta-analysis of randomized trials.

Elgendy IY, Kumbhani DJ, Mahmoud AN, et al.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2016; (88(5)):765-774 doi:10.1002/ccd.26679.

Acute Coronary Syndrome: Current Treatment.

Switaj TL, Christensen SR, Brewer DM

American family physician 2017; (95(4)):232-240.

Early Invasive Strategy and In-Hospital Survival Among Diabetics With Non-ST-Elevation Acute Coronary Syndromes: A Contemporary National Insight.

Mahmoud AN, Elgendy IY, Mansoor H, et al.

Journal of the American Heart Association 2017; (6(3)) doi:10.1161/JAHA.116.005369.

Comparison of Outcome of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation for Non-ST-Elevation Acute Coronary Syndrome.

Chang M, Lee CW, Ahn JM, et al.

The American journal of cardiology 2017; (120(3)):380-386 doi:10.1016/j.amjcard.2017.04.038.

Unstable Angina in the Era of Cardiac Troponin Assays with Improved Sensitivity-A Clinical Dilemma.

Eggers KM, Jernberg T, Lindahl B

The American journal of medicine 2017; (130(12)):1423-1430.e5 doi:10.1016/j.amjmed.2017.05.037.

Precatheterization Use of P2Y12 Inhibitors in Non-ST-Elevation Myocardial Infarction Patients Undergoing Early Cardiac Catheterization and In-Hospital Coronary Artery Bypass Grafting: Insights From the National Cardiovascular Data Registry®.

Badri M, Abdelbaky A, Li S, et al.

Journal of the American Heart Association 2017; (6(9)) doi:10.1161/JAHA.117.006508.

0/1-Hour Triage Algorithm for Myocardial Infarction in Patients With Renal Dysfunction.

Twerenbold R, Badertscher P, Boeddinghaus J, et al.

Circulation 2018; (137(5)):436-451 doi:10.1161/CIRCULATIONAHA.117.028901.

[Acute coronary syndrome in older people].

Eckner D, Popp S, Wicklein S, Pauschinger M

Zeitschrift fur Gerontologie und Geriatrie 2018; (51(4)):461-475 doi:10.1007/s00391-018-1411-y.

2018 Guidelines of the Taiwan Society of Cardiology, Taiwan Society of Emergency Medicine and Taiwan Society of Cardiovascular Interventions for the management of non ST-segment elevation acute coronary syndrome.

Li YH, Wang YC, Wang YC, et al.

Journal of the Formosan Medical Association = Taiwan yi zhi 2018; (117(9)):766-790 doi:10.1016/j.jfma.2018.06.002.

Effects of lowest-dose vs. highest-dose pitavastatin on coronary neointimal hyperplasia at 12-month follow-up in type 2 diabetic patients with non-ST elevation acute coronary syndrome: an optical coherence tomography analysis.

Lim JW, Jeong HS, Hong SJ, et al.

Heart and vessels 2019; (34(1)):62-73 doi:10.1007/s00380-018-1227-0.

Prospective Validation of the 0/1-h Algorithm for Early Diagnosis of Myocardial Infarction.

Twerenbold R, Neumann JT, Sörensen NA, et al.

Journal of the American College of Cardiology 2018; (72(6)):620-632 doi:10.1016/j.jacc.2018.05.040.

Diagnostic performance of high sensitive troponin in non-ST elevation acute coronary syndrome.

Velilla Moliner J, Gros Bañeres B, Povar Marco J, et al.

Medicina intensiva 2020; (44(2)):88-95 doi:10.1016/j.medin.2018.07.014.

Clinical Policy: Critical Issues in the Evaluation and Management of Emergency Department Patients With Suspected Non-ST-Elevation Acute Coronary Syndromes.

, Tomaszewski CA, Nestler D, et al.

Annals of emergency medicine 2018; (72(5)):e65-e106 doi:10.1016/j.annemergmed.2018.07.045.

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.

Schwartz GG, Steg PG, Szarek M, et al.

The New England journal of medicine 2018; (379(22)):2097-2107 doi:10.1056/NEJMoa1801174.

Pre-hospital risk assessment in suspected non-ST-elevation acute coronary syndrome: A prospective observational study.

van Dongen DN, Tolsma RT, Fokkert MJ, et al.

European heart journal. Acute cardiovascular care 2020; (9(1_suppl)):5-12 doi:10.1177/2048872618813846.

Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients With Non-ST-Elevation Myocardial Infarction and Left Main or Multivessel Coronary Disease.

Freitas P, Madeira M, Raposo L, et al.

The American journal of cardiology 2019; (123(5)):717-724 doi:10.1016/j.amjcard.2018.11.052.

Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.

Kofoed KF, Kelbæk H, Hansen PR, et al.

Circulation 2018; (138(24)):2741-2750 doi:10.1161/CIRCULATIONAHA.118.037152.

Coronary microvascular dysfunction in patients with acute coronary syndrome and no obstructive coronary artery disease.

De Vita A, Manfredonia L, Lamendola P, et al.

Clinical research in cardiology : official journal of the German Cardiac Society 2019; (108(12)):1364-1370 doi:10.1007/s00392-019-01472-4.

Meta-analysis of optimal timing of coronary intervention in non-ST-elevation acute coronary syndrome.

Barbarawi M, Kheiri B, Zayed Y, et al.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2020; (95(2)):185-193 doi:10.1002/ccd.28280.

Treatment practices and lipid profile of patients with acute coronary syndrome: results from a tertiary care hospital.

Farmakis I, Zafeiropoulos S, Kartas A, et al.

Acta cardiologica 2020; (75(6)):527-534 doi:10.1080/00015385.2019.1626087.

Health-related quality of life and exercise-based cardiac rehabilitation in contemporary acute coronary syndrome patients: a systematic review and meta-analysis.

Candelaria D, Randall S, Ladak L, Gallagher R

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2020; (29(3)):579-592 doi:10.1007/s11136-019-02338-y.

Indications for an early invasive strategy in NSTE-ACS patients.

Zwart B, Ten Berg JM, van 't Hof AW, et al.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2020; (28(3)):131-135 doi:10.1007/s12471-019-01337-5.

Physical exertion as a trigger of acute coronary syndrome caused by plaque erosion.

Kato A, Minami Y, Katsura A, et al.

Journal of thrombosis and thrombolysis 2020; (49(3)):377-385 doi:10.1007/s11239-020-02074-y.

Revascularization for Coronary Artery Disease: Principle and Challenges.

Gu D, Qu J, Zhang H, Zheng Z

Advances in experimental medicine and biology 2020; (1177()):75-100 doi:10.1007/978-981-15-2517-9_3.

Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial.

Gimbel M, Qaderdan K, Willemsen L, et al.

Lancet (London, England) 2020; (395(10233)):1374-1381 doi:10.1016/S0140-6736(20)30325-1.

Application of the fourth universal definition of myocardial infarction in clinical practice.

Mair J, Cullen L, Giannitsis E, et al.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2020; (25(4)):322-330 doi:10.1080/1354750X.2020.1764108.

Antithrombotic PreTreatment and Invasive Strategies in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome.

Camaro C, Damman P

Journal of clinical medicine 2020; (9(8)) doi:10.3390/jcm9082578.

Cardiac troponins: are there any differences between T and I?

Perrone MA, Storti S, Salvadori S, et al.

Journal of cardiovascular medicine (Hagerstown, Md.) 2021; (22(11)):797-805 doi:10.2459/JCM.0000000000001155.

Prognostic value of GRACE score for in-hospital and 6 months outcomes after non-ST elevation acute coronary syndrome.

Kumar D, Ashok A, Saghir T, et al.

The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology 2021; (73(1)):22 doi:10.1186/s43044-021-00146-9.

Cardiac Troponin Thresholds and Kinetics to Differentiate Myocardial Injury and Myocardial Infarction.

Wereski R, Kimenai DM, Taggart C, et al.

Circulation 2021; (144(7)):528-538 doi:10.1161/CIRCULATIONAHA.121.054302.

Importance of Risk Assessment in Timing of Invasive Coronary Evaluation and Treatment of Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome: Insights From the VERDICT Trial.

Butt JH, Kofoed KF, Kelbæk H, et al.

Journal of the American Heart Association 2021; (10(19)):e022333 doi:10.1161/JAHA.121.022333.

Assessment of Pretreatment With Oral P2Y12 Inhibitors and Cardiovascular and Bleeding Outcomes in Patients With Non-ST Elevation Acute Coronary Syndromes: A Systematic Review and Meta-analysis.

Dawson LP, Chen D, Dagan M, et al.

JAMA network open 2021; (4(11)):e2134322 doi:10.1001/jamanetworkopen.2021.34322.

Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction : An International Collaborative Meta-analysis.

Chiang CH, Chiang CH, Pickering JW, et al.

Annals of internal medicine 2022; (175(1)):101-113 doi:10.7326/M21-1499.

Diagnostic Performance of Novel Troponin Algorithms for the Rule-Out of Non-ST-Elevation Acute Coronary Syndrome.

Tjora HL, Steiro OT, Langørgen J, et al.

Clinical chemistry 2022; (68(2)):291-302 doi:10.1093/clinchem/hvab225.

Dynamic changes in electrocardiographic findings between initial and follow-up electrocardiography: The role of the T/QRS ratio.

Choi Y, Lee JH

The American journal of emergency medicine 2022; (54()):8-14 doi:10.1016/j.ajem.2022.01.033.

Diagnosis and Treatment of Acute Coronary Syndromes: A Review.

Bhatt DL, Lopes RD, Harrington RA

JAMA 2022; (327(7)):662-675 doi:10.1001/jama.2022.0358.

Immediate and early percutaneous coronary intervention in very high-risk and high-risk non-ST segment elevation myocardial infarction patients.

Lupu L, Taha L, Banai A, et al.

Clinical cardiology 2022; (45(4)):359-369 doi:10.1002/clc.23781.

External validation of the GRACE risk score and the risk-treatment paradox in patients with acute coronary syndrome.

van der Sangen NMR, Azzahhafi J, Chan Pin Yin DRPP, et al.

Open heart 2022; (9(1)) doi:10.1136/openhrt-2022-001984.

Prehospital risk assessment in patients suspected of non-ST-segment elevation acute coronary syndrome: a systematic review and meta-analysis.

Demandt JPA, Zelis JM, Koks A, et al.

BMJ open 2022; (12(4)):e057305 doi:10.1136/bmjopen-2021-057305.

[Management of acute coronary syndrome without ST-segment elevation].

Rubini Gimenez M, Thiele H, Pöss J

Herz 2022; (47(4)):381-392 doi:10.1007/s00059-022-05120-y.

High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain.

Sandoval Y, Apple FS, Mahler SA, et al.

Circulation 2022; (146(7)):569-581 doi:10.1161/CIRCULATIONAHA.122.059678.

Meta-analysis Comparing Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting for Non-ST Elevation Acute Coronary Syndrome in Patients With Multivessel or Left Main Disease.

Barssoum K, Kumar A, Rai D, et al.

Current problems in cardiology 2022; (47(10)):101306 doi:10.1016/j.cpcardiol.2022.101306.

Assessment of Oxygen Supply-Demand Imbalance and Outcomes Among Patients With Type 2 Myocardial Infarction: A Secondary Analysis of the High-STEACS Cluster Randomized Clinical Trial.

Bularga A, Taggart C, Mendusic F, et al.

JAMA network open 2022; (5(7)):e2220162 doi:10.1001/jamanetworkopen.2022.20162.

Synthesized 18-Lead Electrocardiogram in Diagnosing Posterior Stemi-Equivalent Acute Coronary Syndrome in Patients with NSTEMI.

Horie T, Hamaya R, Sugiyama T, et al.

Cardiology research and practice 2022; (2022()):9582174 doi:10.1155/2022/9582174.

A Left Atrial Myxoma Masquerading As Acute Coronary Syndrome.

Nepal S, Caicedo Murillo ML, Ojha K, Lamichhane M

Cureus 2022; (14(9)):e29300 doi:10.7759/cureus.29300.

Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis.

Dibben GO, Faulkner J, Oldridge N, et al.

European heart journal 2023; (44(6)):452-469 doi:10.1093/eurheartj/ehac747.

Benefit of Combination Ezetimibe/Simvastatin Among High-Risk Populations: Lessons from the IMPROVE-IT Trial.

Oliver W, Giugliano RP

Current atherosclerosis reports 2023; (25(3)):85-93 doi:10.1007/s11883-023-01084-4.

Long-term clinical outcomes in patients with non-ST-segment Elevation Acute Coronary Syndrome and ST-segment elevation myocardial infarction with thrombolysis in myocardial infarction 0 flow.

Aarts BRA, Groenland FTW, Elscot J, et al.

International journal of cardiology. Heart & vasculature 2023; (48()):101254 doi:10.1016/j.ijcha.2023.101254.

[Management of acute coronary syndrome : ESC guidelines 2023].

Buske M, Feistritzer HJ, Jobs A, Thiele H

Herz 2024; (49(1)):5-14 doi:10.1007/s00059-023-05222-1.

Timing of coronary angiography and use of antiplatelet pretreatment in patients with NSTEACS in Spain.

Díez-Delhoyo F, López Lluva MT, Cepas-Guillén P, et al.

Revista espanola de cardiologia (English ed.) 2024; (77(3)):234-242 doi:10.1016/j.rec.2023.07.013.

One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes.

Cao D, Vranckx P, Valgimigli M, et al.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2024; (20(10)):e630-e642 doi:10.4244/EIJ-D-23-00658.

Elevated Troponins and Diagnosis of Non-ST-Elevation Myocardial Infarction in the Emergency Department.

Ali F, Arshad K, Szpunar S, Daher E

Cureus 2024; (16(5)):e59910 doi:10.7759/cureus.59910.

Coronary computed tomography angiography improves assessment of patients with acute chest pain and inconclusively elevated high-sensitivity troponins.

Arslan M, Schaap J, van Gorsel B, et al.

European radiology 2025; (35(2)):789-797 doi:10.1007/s00330-024-10930-1.

Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.

Brown TM, Pack QR, Aberegg E, et al.

Circulation 2024; (150(18)):e328-e347 doi:10.1161/CIR.0000000000001289.

Systemic immune inflammatory response index (SIIRI) in acute myocardial infarction.

Muheeb G, Yusuf J, Mehta V, et al.

Coronary artery disease 2025; (36(2)):139-150 doi:10.1097/MCA.0000000000001454.

Percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registry.

Omerovic E, Råmunddal T, Petursson P, et al.

European heart journal 2025; (46(6)):518-531 doi:10.1093/eurheartj/ehae700.

Percutaneous coronary intervention versus coronary artery bypass in treatment of non-ST-segment elevation acute syndromes: a systematic review and meta-analysis study.

Khalifehsoltani A, Oghenemaro EF, Zwamel AH, et al.

European journal of translational myology 2025; (35(1)) doi:10.4081/ejtm.2024.12930.

Type 2 myocardial infarction: challenges in diagnosis and treatment.

Chapman AR, Taggart C, Boeddinghaus J, et al.

European heart journal 2025; (46(6)):504-517 doi:10.1093/eurheartj/ehae803.

2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Rao SV, O'Donoghue ML, Ruel M, et al.

Circulation 2025; (151(13)):e771-e862 doi:10.1161/CIR.0000000000001309.

Value of upfront coronary computed tomography angiography in patients with non-ST-segment elevation acute coronary syndrome.

Lu ZF, Yin WH, Lu B

The international journal of cardiovascular imaging 2025; (41(4)):733-742 doi:10.1007/s10554-025-03360-7.

Latest evidence on assessment and invasive management of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) in the older population.

Gill K, Mills GB, Wang W, et al.

Expert review of cardiovascular therapy 2025; (23(3)):73-86 doi:10.1080/14779072.2025.2476125.

New Right Bundle Branch Block: A Benign Variant or an Ominous Sign?

Myint Thu T, Hegazy A, Dancy L

Cureus 2025; (17(6)):e86103 doi:10.7759/cureus.86103.

Revascularization strategies in Non-ST segment elevation myocardial infarction: the clash continues.

Zuccarelli V, Giunti F, Chiarito M, et al.

Frontiers in cardiovascular medicine 2025; (12()):1614843 doi:10.3389/fcvm.2025.1614843.

Great debate: the universal definition of myocardial infarction is flawed and should be put to rest.

Mueller C, White HD, Lopez-Ayala P, et al.

European heart journal 2025; doi:10.1093/eurheartj/ehaf641.

Dyslipidemia Treatment in Patients with Acute Coronary Syndrome: Is It Time to Move to Combination Therapy?

Brie DM, Mornoș C, Adam O, et al.

Journal of clinical medicine 2025; (14(18)) doi:10.3390/jcm14186445.

Immediate versus delayed coronary angiography in patients with non-ST segment elevation acute coronary syndrome complicated with acute decompensated heart failure: The EARLY-HF randomized clinical trial.

Lim Y, Park S, Joo D, et al.

Cardiovascular revascularization medicine : including molecular interventions 2026; (83()):32-39 doi:10.1016/j.carrev.2025.09.016.

Diagnosis, risk stratification, and early management of non-ST-segment elevation acute coronary syndrome.

Kovacevic M, Jones DA, Thiele H, et al.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2025; (21(23)):e1399-e1423 doi:10.4244/EIJ-D-25-00100.

Non-ST-segment elevation acute coronary syndrome: understanding the full spectrum to guide management.

Savonitto S, Alpert JS, Thiele H, et al.

European heart journal 2025; doi:10.1093/eurheartj/ehaf958.

Comparison of the European Society of Cardiology 0/1-Hour and High-Sensitivity Troponin in the Evaluation of Patients With Suspected Acute Coronary Syndrome 0/2-or-0/3-Hour Algorithms for Rapid Myocardial Infarction Diagnosis: A Prospective Multicenter Study.

Glaeser J, Lopez-Ayala P, Kellner C, et al.

Journal of the American College of Cardiology 2026; (87(17)):2261-2278 doi:10.1016/j.jacc.2025.12.056.

Real-world adoption of the 2023 European Society of Cardiology guidelines regarding antiplatelet strategies in acute coronary syndromes: Insights from the European READAPT-2 survey.

Angiolillo DJ, Erlinge D, Gale CP, et al.

International journal of cardiology 2026; (453()):134288 doi:10.1016/j.ijcard.2026.134288.

Impact of the risk-treatment paradox on in-hospital and long-term outcomes in patients with very high-risk non-ST-elevation acute coronary syndrome.

Nesova A, Vorobeva D, Ryabov V

The Indian journal of medical research 2026; (163(1)):55-61.

Singapore expert consensus on optimising lipid-lowering strategies in acute coronary syndrome: A modified Delphi study.

Tan RS, Yap J, Yeo C, et al.

Annals of the Academy of Medicine, Singapore 2026; (55(6)):318-331 doi:10.47102/annals-acadmedsg.2025459.

Effectiveness of Cardiac Telerehabilitation in Improving Functional Capacity, Quality Of Life and Cardiovascular Outcomes in Patients After Acute Coronary Syndrome and/or Coronary Revascularisation (PCI/CABG): A Systematic Review Comparing Telerehabilitation With Traditional Cardiac Rehabilitation.

Nowaczyk A

Medical science monitor : international medical journal of experimental and clinical research 2026; (32()):e953366 doi:10.12659/MSM.953366.

Clinical outcomes of invasive versus conservative strategies for very high-risk patients with non-ST-elevation acute coronary syndrome: an observational cohort study in a real-world population of China.

Liu Y, Zeng L, Yu S, et al.

EClinicalMedicine 2026; (97()):104071 doi:10.1016/j.eclinm.2026.104071.

Clinical characteristics and diagnostic challenges of non-ST-segment elevation acute coronary syndrome patients with normal electrocardiograms: a review.

Zhang Y, Shen Y

Frontiers in cardiovascular medicine 2026; (13()):1835982 doi:10.3389/fcvm.2026.1835982.

The evolution of dual antiplatelet therapy in patients with coronary artery disease.

Simonsson M, James S, Ten Berg JM, Gigante B

European heart journal open 2026; (6(4)):oeag107 doi:10.1093/ehjopen/oeag107.